` Comparison: 268600 vs TMO - Alpha Spread

C
268600
vs
TMO

Over the past 12 months, Cellivery Therapeutics Inc has underperformed TMO, delivering a return of 0% compared to the TMO's 3% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
268600
TMO
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

C
Intrinsic Value
Not Available
TMO Intrinsic Value
491.61 USD
Overvaluation 3%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
C
Cellivery Therapeutics Inc
KOSDAQ:268600
6 680 KRW
Thermo Fisher Scientific Inc
NYSE:TMO
504.82 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
268600, TMO

268600
TMO
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
C
Cellivery Therapeutics Inc
Revenue
Thermo Fisher Scientific Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
268600, TMO

268600
TMO
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Thermo Fisher Scientific Inc
NYSE:TMO
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Cellivery Therapeutics Inc
2.3%
TMO
41.5%

Operating Margin

Cellivery Therapeutics Inc
-60.9%
TMO
18.2%

Net Margin

Cellivery Therapeutics Inc
-25%
TMO
15%

FCF Margin

Cellivery Therapeutics Inc
4.8%
TMO
14.1%

ROE

Cellivery Therapeutics Inc
28.3%
TMO
13%

ROA

Cellivery Therapeutics Inc
-22.9%
TMO
6.5%

ROIC

Cellivery Therapeutics Inc
-56.9%
TMO
7.9%

ROCE

Cellivery Therapeutics Inc
65.2%
TMO
9.1%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
268600, TMO

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
268600, TMO

Loading
268600
TMO
Difference
www.alphaspread.com

Performance By Year
268600, TMO

Loading
268600
TMO
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 268600 to other stocks
0KHE
PerkinElmer Inc
P
DHR
Danaher Corp
207940
Samsung Biologics Co Ltd
LONN
Lonza Group AG
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account